Literature DB >> 21769707

Morphological state as a predictor for reintervention and mortality after EVAR for AAA.

Tomas Ohrlander1, Magnus Dencker, Stefan Acosta.   

Abstract

PURPOSE: This study was designed to assess aorto-iliac morphological characteristics in relation to reintervention and all-cause long-term mortality in patients undergoing standard EVAR for infrarenal AAA.
METHODS: Patients treated with EVAR (Zenith(®) Stentgrafts, Cook) between May 1998 and February 2006 were prospectively enrolled in a computerized database where comorbidities and preoperative aneurysm morphology were entered. Reinterventions and mortality were checked until December 1, 2010. Median follow-up time was 68 months.
RESULTS: A total of 304 patients were included, of which 86% were men. Median age was 74 years. The reintervention rate was 23.4% (71/304). A greater diameter of the common iliac artery (p = 0.037; hazard ratio (HR) 1.037 [1.002-1.073]) was an independent factor for an increased number of reinterventions. The 30-day mortality rate was 3.0% (9/304). Aneurysm-related deaths due to AAA occurred in 4.9% (15/304). Five patients died due to a concomitant ruptured thoracic aortic aneurysm. The mortality until end of follow-up was 54.3% (165/304). The proportion of deaths caused by vascular diseases was 61.6%. The severity of angulation of the iliac arteries (p = 0.014; HR 1.018 [95% confidence interval (CI) 1.004-1.033]) and anemia (p = 0.044; HR 2.79 [95% CI 1.029-7.556]) remained as independent factors associated with all-cause long-term mortality. The crude reintervention-free survival rate at 1, 3, and 5 years was 84.5%, 64.8%, and 51.6%, respectively.
CONCLUSIONS: The initial aorto-iliac morphological state in patients scheduled for standard EVAR for AAA seems to be strongly related to the need for reinterventions and long-term mortality.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21769707     DOI: 10.1007/s00270-011-0229-4

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  6 in total

1.  Claims-based surveillance for reintervention after endovascular aneurysm repair among non-Medicare patients.

Authors:  Jesse A Columbo; Art Sedrakyan; Jialin Mao; Andrew W Hoel; Spencer W Trooboff; Ravinder Kang; Jeremiah R Brown; Philip P Goodney
Journal:  J Vasc Surg       Date:  2019-03-25       Impact factor: 4.268

2.  Technical and clinical outcome of Talent versus Endurant endografts for endovascular aortic aneurysm repair.

Authors:  Birger Mensel; Jens-Peter Kühn; Tobias Träger; Martin Dührkoop; Wolfram von Bernstorff; Christian Rosenberg; Andreas Hoene; Ralf Puls
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

3.  Endovascular aortic repair reduces gluteal oxygenation.

Authors:  Mikkel Taudorf; Michael B Nielsen; Torben V Schroeder; Lars Lönn; Henning B Nielsen
Journal:  Acta Radiol Open       Date:  2019-05-20

4.  What factors counteract mid-term survival following endovascular repair of abdominal aortic aneurysms?

Authors:  Ertekin Utku Ünal; Hakkı Zafer İscan; Bekir Bogachan Akkaya; İsa Civelek; Mehmet Karahan; Ece Celikten; Göktan Askin; Hayrettin Levent Mavioğlu; Mehmet Ali Özatik
Journal:  Kardiochir Torakochirurgia Pol       Date:  2021-05-15

5.  Re-interventions after endovascular aortic repair for infrarenal abdominal aneurysms: a retrospective cohort study.

Authors:  Håkan Roos; Henrik Djerf; Ludvig Brisby Jeppsson; Victoria Fröjd; Tomas Axelsson; Anders Jeppsson; Mårten Falkenberg
Journal:  BMC Cardiovasc Disord       Date:  2016-06-06       Impact factor: 2.298

6.  Comparable mid-term survival in patients undergoing elective fenestrated endovascular aneurysm repair and endovascular aneurysm repair for abdominal aortic aneurysm.

Authors:  Sofia Nessvi; Anders Gottsäter; Stefan Acosta
Journal:  SAGE Open Med       Date:  2014-01-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.